Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Monica Haglund"'
Autor:
Sigrid Dentler, Monica Haglund-Dragi´c
Publikováno v:
Moderna Språk, Vol 91, Iss 1 (1997)
Review Article
Externí odkaz:
https://doaj.org/article/8ee73cb911b743f18a10d873c8a3c83b
Autor:
Maria Planck, Sofi Isaksson, Pär-Ola Bendahl, Annette Salomonsson, Per Jönsson, Leif Johansson, Karin Jirström, Monica Haglund, Mats Jönsson, Alexander Gaber, Åke Borg, Johan Staaf
Publikováno v:
Virchows Archiv. 463:755-764
We investigated the epidermal growth factor receptor (EGFR) status in early stage lung cancer in Southern Sweden, a population for which there are no previous reports on the EGFR mutation frequency. Three hundred fifty small cell lung cancers, adenoc
Publikováno v:
Breast Cancer Research and Treatment. 120:491-498
Triple-negative breast cancer (TNB) has poor prognosis and moreover patients with TNB do not benefit from established targeted drugs with endocrine therapy or trastuzumab. The aim of the study was to analyze the prevalence of candidate biomarkers in
Autor:
Lisa Rydén, Monica Haglund, Pär-Ola Bendahl, Thomas Hatschek, Aleksandra Kolaric, Anikó Kovács, Ann Olsson, Hans Olsson, Carina Strand, Mårten Fernö, null Swedish Her2 Analysis Group
Publikováno v:
Acta oncologica (Stockholm, Sweden). 48(6)
HER2 is a treatment predictive factor for the effect of trastuzumab and associated with poor prognosis in breast cancer. The analysis of HER2 must be performed with good quality, with regard to both the immunohistochemical (IHC) and in situ hybridiza
Publikováno v:
Lakartidningen. 105(32-33)
Autor:
Otto Ljungberg, Lars Magnus Bjursten, Roy Ehrnström, Tommy Andersson, Béla Veress, Monica Haglund, Clas Lindström
Publikováno v:
International journal of cancer. 122(4)
Dietary factors play essential roles in gastric carcinogenesis. We recently found that dietary supplementation with NaHCO3 significantly increased the development of gastric cancer in a rat gastric stump model. Here, we analysed nontransformed gastri
Autor:
Monica Haglund, Bodil Ohlsson, Sabina Janciauskiene, Béla Veress, Agneta Montgomery, Anders Wallmark
Publikováno v:
Gastroenterology; 132(1), pp 45-51 (2007)
Background & Aims: A 30-year-old woman, treated with buserelin, an analogue of gonadotropin-releasing hormone (GnRH) (also called luteinizing hormone-releasing hormone, LH-RH), developed chronic intestinal pseudo-obstruction (CIPO). The sudden onset
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e64cca4df4a828cf8e02a5129f37fd4
http://lup.lub.lu.se/record/164711
http://lup.lub.lu.se/record/164711
Publikováno v:
Lakartidningen. 102(10)
Between 20 and 30 per cent of all breast cancers show an overexpression of the growth factor HER2 and this implies a worse prognosis. Metastasising breast cancer that overexpress HER2 can effectively be treated with trastuzumab (Herceptin). In order
Publikováno v:
Journal of Thoracic Oncology. 2:S721
Publikováno v:
Language. 69:859